LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 27 filers reported holding LANTERN PHARMA INC in Q3 2022. The put-call ratio across all filers is 4.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130 | -48.6% | 38,100 | -15.1% | 0.00% | – |
| Q2 2023 | $253 | +112.6% | 44,900 | +82.5% | 0.00% | – |
| Q1 2023 | $119 | -6.3% | 24,600 | +16.6% | 0.00% | – |
| Q4 2022 | $127 | -99.9% | 21,100 | -0.9% | 0.00% | – |
| Q3 2022 | $102,000 | -19.0% | 21,300 | -3.6% | 0.00% | – |
| Q2 2022 | $126,000 | +63.6% | 22,100 | +106.5% | 0.00% | – |
| Q1 2022 | $77,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 365,930 | $1,721,000 | 0.42% |
| CM Management, LLC | 50,000 | $239,000 | 0.27% |
| WOLFF WIESE MAGANA LLC | 30,462 | $146,000 | 0.12% |
| Redmond Asset Management, LLC | 49,502 | $237,000 | 0.09% |
| CARLSON CAPITAL L P | 168,000 | $803,000 | 0.06% |
| NewEdge Advisors, LLC | 171,019 | $817,000 | 0.01% |
| Sigma Planning Corp | 17,500 | $84,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,984 | $19,000 | 0.00% |
| NORTHERN TRUST CORP | 12,629 | $60,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |